REGULATION OF ENDOTHELIAL PERMEABILITY BY BETA-ADRENOCEPTOR AGONISTS - CONTRIBUTION OF BETA(1)-ADRENOCEPTOR AND BETA(2)-ADRENOCEPTORS

被引:36
作者
ZINK, S
ROSEN, P
SACKMANN, B
LEMOINE, H
机构
[1] DIABET RES INST,AUFM HENNEKAMP 65,W-4000 DUSSELDORF 1,GERMANY
[2] HEINRICH HEINE UNIV,BIOMED RES CTR,MOLEC DRUG RES GRP,DUSSELDORF,GERMANY
关键词
ENDOTHELIAL CELL; PERMEABILITY REGULATION; BETA-ADRENOCEPTOR SUBTYPE; CATECHOLAMINE; SYMPATHOMIMETICS;
D O I
10.1016/0167-4889(93)90206-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The barrier function of cultured, macrovascular endothelial cells derived from bovine aorta was analyzed using confluent monolayers of cells and measuring the exchange of fluorescein dextrans of different molecular masses. The effects of beta-adrenoceptor agonists with different selectivity for beta1- and beta2-adrenoceptors (AR) were investigated. Formoterol, a novel high-affinity agonist for beta2AR recently introduced in the treatment of bronchial asthma, showed a significant reduction of cell permeability with subnanomolar concentrations, whereas the catecholamines (-)-isoproterenol and (-)-norepinephrine only showed significant effects with micromolar concentrations. In order to elucidate if this difference in potential to regulate cell permeability is related to appropriate changes in the selectivity and affinity of the agonists for beta2AR, we investigated the betaAR-coupled adenylate cyclase (AC) in membranes from endothelial cells and compared AC stimulation with the binding of agonists to the receptors using [I-125](-)-iodopindolol as radioligand. Beta-Adrenoceptors revealed to be closely coupled to AC as assessed by a similar magnitude of effects by receptor agonists in comparison to GTP analogues and direct stimulants of AC activity. AC activity was increased by formoterol in parallel to its receptor occupancy of beta2AR with nanomolar concentrations which were 50-fold higher than those used for the regulation of cell permeability indicating the existence of spare receptors. In contrast to formoterol, the catecholamines (-)-isoproterenol and (-)-norepinephrine stimulated AC activity through both beta1AR and beta2AR. From the overproportional high contribution of beta1AR to AC stimulation (42%) in comparison to its low fraction (13%) in receptor binding we calculated that beta1AR is 3-4-fold more effectively coupled to AC than beta2AR.
引用
收藏
页码:286 / 298
页数:13
相关论文
共 55 条
[1]  
ABELDA SM, 1988, J APPL PHYSIOL, V64, P308
[2]   CHARACTERIZATION OF BETA-ADRENOCEPTORS ON CULTURED ENDOTHELIAL-CELLS BY RADIOLIGAND BINDING [J].
AHMAD, S ;
CHRETIEN, P ;
DANIEL, EE ;
SHEN, SH .
LIFE SCIENCES, 1990, 47 (25) :2365-2370
[3]   FORMOTEROL, A NEW LONG-ACTING SELECTIVE BETA2-ADRENERGIC RECEPTOR AGONIST - DOUBLE-BLIND COMPARISON WITH SALBUTAMOL AND PLACEBO IN CHILDREN WITH ASTHMA [J].
BECKER, AB ;
SIMONS, FER ;
MCMILLAN, JL ;
FARIDY, T .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 84 (06) :891-895
[4]   CULTURE OF ARTERIAL ENDOTHELIAL CELLS - CHARACTERIZATION AND GROWTH OF BOVINE AORTIC CELLS [J].
BOOYSE, FM ;
SEDLAK, BJ ;
RAFELSON, ME .
THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1975, 34 (03) :825-839
[5]   PERMEABILITY OF SINGLE CAPILLARIES TO INTERMEDIATE-SIZED COLORED SOLUTES [J].
CURRY, FE ;
HUXLEY, VH ;
ADAMSON, RH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1983, 245 (03) :H495-H505
[6]  
DELVECCHIO PJ, 1987, FASEB J, V46, P2511
[7]   CGP 20712-A - A USEFUL TOOL FOR QUANTITATING BETA-1-ADRENOCEPTOR AND BETA-2-ADRENOCEPTORS [J].
DOOLEY, DJ ;
BITTIGER, H ;
REYMANN, NC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 130 (1-2) :137-139
[8]  
DVORAK HF, 1986, NEW ENGL J MED, V315, P1650
[9]   IMPROVED EVALUATION OF BINDING OF LIGANDS TO MEMBRANES CONTAINING SEVERAL RECEPTOR-SUBTYPES [J].
EHLE, B ;
LEMOINE, H ;
KAUMANN, AJ .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1985, 331 (01) :52-59
[10]   (+/)(IODO-125)CYANOPINDOLOL, A NEW LIGAND FOR BETA-ADRENOCEPTORS - IDENTIFICATION AND QUANTITATION OF SUBCLASSES OF BETA-ADRENOCEPTORS IN GUINEA-PIG [J].
ENGEL, G ;
HOYER, D ;
BERTHOLD, R ;
WAGNER, H .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1981, 317 (04) :277-285